Doubts over long term impact of group education for diabetes patients

The benefits of a one-off group education programme for people with newly diagnosed type 2 diabetes are not sustained over the long term, concludes a study published on BMJ today.

Type 2 diabetes is a serious and progressive condition. In the long term, it can lead to complications such as blindness, , and amputation, and it is well recognised that people with diabetes need to take personal responsibility for managing their symptoms.

In the UK, the Diabetes National Service Framework and the National Institute for Health and Clinical Excellence (NICE) promote structured education for all patients from diagnosis.

A previous trial showed that the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) programme changed patients' attitudes towards their condition and improved their health over 12 months, but the longer term impact is not known.

So researchers set out to measure whether these benefits are sustained over three years.

They assessed 731 of the 824 patients who took part in the original trial.

The received a six-hour structured group education programme delivered in the community by two trained healthcare professional educators. The control group received usual care by their team.

Biomedical data such as HbA1c (a measure of blood sugar levels), cholesterol and body weight were collected and patients were asked about their lifestyle, quality of life, illness beliefs, depression, emotional impact of diabetes, and medication use.

There were no differences between the two groups in biomedical or lifestyle outcomes at three years, although there were sustained improvements in some illness beliefs.

A second study also published today found a programme called Talking Diabetes, (aimed at improving healthcare professionals' consulting skills for children with ) had no effect on or quality of life at 12 months.

An accompanying editorial says these results are disappointing and suggests we should "focus again on the setting of appropriate targets by professionals who care for patients with diabetes and the patients themselves."

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

How does DPP-4 inhibition affect liver function?

Jan 27, 2015

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

Team shows why wound healing is impaired in diabetics

Jan 26, 2015

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.